Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs FuturHealth

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and FuturHealth head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 429 · Grade C

FuturHealth

Visit FuturHealth Full brief →

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 56 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make FuturHealth a bad call — it's best for readers comparing brand options and willing to check the full recurring cost. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
58
Supply Reliability
95
65
Transparency
90
32
Access Breadth
93
52
Clinical Oversight
92
72
Track Record
88
58
CoreAge RxBrief Score 94 · 56FuturHealth

Price, coverage & the tracker

CoreAge RxFuturHealth
Brief Score94/100 (A)56/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

Brand Wegovy pill and pen listed. Confirm the recurring total.

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

Brand Zepbound KwikPen listed. Confirm the recurring total.

CoverageUS only; restrictions by state, confirmed at intakeConfirm program and pharmacy coverage for your address.
Brand-name accessNot confirmedYes
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

FuturHealth: Ask what the same prescription and care will cost on renewal.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.